Congenital adrenal hyperplasia - Pharmacologic interventions from the prenatal phase to adulthood

Pharmacology and Therapeutics

Volumn 132, Issue 1, 2011, Pages 1-14

  Claahsen Van Der Grinten, H L ^a   Stikkelbroeck, N M M L ^a   Otten, B J ^a   Hermus, A R M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adults; Children; Congenital adrenal hyperplasia; Glucocorticoid treatment

Indexed keywords

ALDOSTERONE; ANDROSTENEDIONE; CALCIUM; CHOLESTEROL; CORTICOTROPIN; CREATININE; DEXAMETHASONE; ESTRADIOL; FLUDROCORTISONE; FOLLITROPIN; GLUCOCORTICOID; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; HYDROXYPROGESTERONE; INHIBIN B; LUTEINIZING HORMONE; MINERALOCORTICOID; POTASSIUM; PREDNISONE; PROGESTERONE; RENIN; SODIUM; STEROID 21 MONOOXYGENASE; TESTOSTERONE; VITAMIN D;

ADRENAL CORTEX INSUFFICIENCY; ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; BIOEQUIVALENCE; BLOOD SAMPLING; BODY TEMPERATURE; BONE DENSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CONGENITAL ADRENAL HYPERPLASIA; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; CRITICAL ILLNESS; CUSHING SYNDROME; DIARRHEA; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; EMERGENCY CARE; EMOTIONAL STRESS; ESTRADIOL BLOOD LEVEL; FEMALE INFERTILITY; FERTILITY; FEVER; FOLLITROPIN BLOOD LEVEL; GENE THERAPY; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; GROWTH RETARDATION; HEADACHE; HUMAN; HYDROCORTISONE RELEASE; HYPERALDOSTERONISM; HYPERANDROGENISM; HYPERKALEMIA; HYPOALDOSTERONISM; HYPONATREMIA; HYPOVOLEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN RESISTANCE; LUTEINIZING HORMONE BLOOD LEVEL; MALE INFERTILITY; MONOTHERAPY; NONHUMAN; OSTEOPOROSIS; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRENATAL PERIOD; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RECOMMENDED DRUG DOSE; REVIEW; SHOCK; SODIUM BLOOD LEVEL; STEM CELL TRANSPLANTATION; STEROID ANALYSIS; STRESS; TESTOSTERONE BLOOD LEVEL; UNCONSCIOUSNESS; VIRILIZATION; VIRUS INFECTION; VITAMIN SUPPLEMENTATION; VOMITING; WEIGHT REDUCTION;

ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGE FACTORS; CHILD; CIRCADIAN RHYTHM; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUDROCORTISONE; GLUCOCORTICOIDS; HUMANS; INFANT; MALE; PREGNANCY; THERAPEUTIC EQUIVALENCY;

EID: 79960605992     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.05.004     Document Type: Review

References (143)

1. A. Agha, and J.P. Monson Modulation of glucocorticoid metabolism by the growth hormone-IGF-1 axis Clin Endocrinol (Oxf) 66 2007 459 465 (Pubitemid 46434930)
2. S. Alesci, W.J. Ramsey, S.R. Bornstein, G.P. Chrousos, P.J. Hornsby, and S. Benvenga Adenoviral vectors can impair adrenocortical steroidogenesis: clinical implications for natural infections and gene therapy Proc Natl Acad Sci U S A 99 11 2002 7484 7489 (Pubitemid 34568717)
3. B.M. Arafah Review: Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods J Clin Endocrinol Metab 91 2006 3725 3745 (Pubitemid 44536835)
4. W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, and S. Hahner The United Kingdom Congenital Adrenal Hyperplasia Adult Study Executive (CaHASE) J Clin Endocrinol Metab 18 2010 [Epub ahead of print]
5. A. Augarten, R. Weissenberg, C. Pariente, and J. Sack Reversible male infertility in late onset congenital adrenal hyperplasia J Endocrinol Invest 14 1991 237 240
6. A. Bachelot, Z. Chakhtoura, D. Samara-Boustani, J. Dulon, P. Touraine, and M. Polak Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency Int J Pediatr Endocrinol 2010, vol. 2010, Article ID 326275, 7 pages. doi:10.1155/2010/326275.
7. A. Balsamo, A. Cicognani, L. Baldazzi, M. Barbaro, F. Baronio, and M. Gennari CYP21 genotype, adult height, and pubertal development in 55 patients treated for 21-hydroxylase deficiency J Clin Endocrinol Metab 88 12 2003 5680 5688 (Pubitemid 38033035)
8. A. Balsamo, L. Baldazzi, S. Menabò, and A. Cicognani Impact of molecular genetics on congenital adrenal hyperplasia management Sex Dev 4 4-5 2010 233 248
9. M. Bidet, C. Bellanne-Chantelot, M.B. Galand-Portier, V. Tardy, L. Billaud, and K. Laborde Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members J Clin Endocrinol Metab 94 5 2009 1570 1578
10. M. Bidet, C. Bellanné-Chantelot, M.B. Galand-Portier, J.L. Golmard, V. Tardy, and Y. Morel Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 95 3 2010 1182 1190
11. H.H. Bode, S.A. Rivkees, D.M. Cowley, K. Pardy, and S. Johnson Home monitoring of 17 hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples J Pediatr 134 2 1999 185 189 (Pubitemid 29089042)
12. W. Bonfig, S. Bechthold, H. Schmidt, D. Knor, and H.P. Schwarz Reduced final height outcome in congenital adrenal hyperplasia and prednisone treatment: deceleration of growth velocity during puberty J Clin Endocrinol Metab 92 2007 1635 1639 (Pubitemid 46997164)
13. W. Bonfig, S. Bechtold Dalla Pozza, H. Schmidt, P. Pagel, D. Knorr, and H.P. Schwarz Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence based recommendation J Clin Endocrinol Metab 9 2009 934 939
14. S.R. Bornstein, E.L. Webster, D.J. Torpy, S.J. Richman, N. Mitsiades, and M. Igel Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation Endocrinology 139 4 1998 1546 1555 (Pubitemid 28513808)
15. D. Bourchier Plasma aldosterone levels in the 1st week of life in infants of less than 30 weeks gestation Eur J Pediatr 164 3 2005 141 145 (Pubitemid 40558176)
16. S.M. Bryan, J.W. Honour, and P.C. Hindmarsh Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion J Clin Endocrinol Metab 94 9 2009 3477 3480
17. T.M. Buckley, and A.F. Schatzberg On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders J Clin Endocrinol Metab 90 5 2005 3106 3114 (Pubitemid 40686371)
18. C. Castelo-Branco, and M. Del Pino Hepatotoxicity during low-dose flutamide treatment for hirsutism Gynecol Endocrinol 25 7 2009 419 422
19. O.A. Castillo, A. Foneron, I. Vidal-Mora, R. Sánchez-Salas, G. Vitagliano, and M. Díaz Bilateral simultaneous laparoscopic adrenalectomy for congenital adrenal hyperplasia: initial experience J Pediatr Urol 7 2011 174 177
20. Z. Chakhtoura, A. Bachelot, D. Samara-Boustani, J.C. Ruiz, B. Donadille, and J. Dulon Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency Eur J Endocrinol 158 6 2008 879 887 (Pubitemid 351837377)
21. E. Charmandari, C.G.D. Brook, and P.C. Hindmarsh Bioavailablility of oral hydrocortisone in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Endocrinol 169 2001 65 70 (Pubitemid 32273215)
22. E. Charmandari, D.R. Matthwews, A. Johnston, C.G.D. Brook, and P.C. Hindmarsh Serum Cortisol and 17 hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory? J Clin Endocrinol Metab 86 2001 4679 4685 (Pubitemid 33020506)
23. E. Charmandari, E.J. Lichtarowiccz-Krynska, P.C. Hindmarsh, A. Johnston, A. Aynsley-Green, and C.G.D. Brook Congenital adrenal hyperplasia: management during critical illness Arch Dis Child 85 2001 26 28
24. E. Charmandari, P.C. Hindmarsh, A. Johnston, and C.G. Brook Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty J Clin Endocrinol Metab 86 2001 2701 2708 (Pubitemid 32545726)
25. E. Charmandari, C.G.D. Brook, and P.C. Hindmarsh Why is management of patients with congenital adrenal hyperplasia more difficult at puberty? Arch Dis Child 86 2002 266 269 (Pubitemid 34289627)
26. E. Charmandari, A. Johnston, J.W. Honour, C.G. Brook, and P.C. Hindmarsh Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia J Pediatr Endocrinol Metab 15 4 2002 435 439 (Pubitemid 34704810)
27. E. Charmandari, C.G. Brook, and P.C. Hindmarsh Classic congenital adrenal hyperplasia and puberty Eur J Endocrinol 151 2004 U77 U82 (Pubitemid 39627059)
28. E. Charmandari, G.P. Chrousos, and D.P. Merke Adrenocorticotropin hypersecretion and pituitary microadenoma following bilateral adrenalectomy in a patient with classic 21-hydroxylase deficiency J Pediatr Endocrinol Metab 18 1 2005 97 101 (Pubitemid 40227878)
29. H.L. Claahsen-van der Grinten, N.M. Stikkelbroeck, C.G. Sweep, A.R. Hermus, and B.J. Otten Fertility in patients with congenital adrenal hyperplasia J Pediatr Endocrinol Metab 19 5 2006 677 685
30. H.L. Claahsen-van der Grinten, K. Noordam, G.F. Borm, and B.J. Otten Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia J Clin Endocrinol Metab 91 4 2006 1205 1209
31. H.L. Claahsen-van der Grinten, B.J. Otten, F.C. Sweep, and A.R. Hermus Repeated successful induction of fertility after replacing hydrocortisone with dexamethasone in a patient with congenital adrenal hyperplasia and testicular adrenal rest tumors Fertil Steril 88 3 2007 705
32. H.L. Claahsen-van der Grinten, B.J. Otten, S. Takahashi, E.J. Meuleman, C. Hulsbergen-van de Kaa, and F.C. Sweep Testicular adrenal rest tumors in adult males with congenital adrenal hyperplasia: evaluation of pituitary-gonadal function before and after successful testis-sparing surgery in eight patients J Clin Endocrinol Metab 92 2 2007 612 615
33. H.L. Claahsen-van der Grinten, F.C. Sweep, J.G. Blickman, A.R. Hermus, and B.J. Otten Prevalence of testicular adrenal rest tumours in male children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Eur J Endocrinol 157 3 2007 339 344 (Pubitemid 47603539)
34. H.L. Claahsen-van der Grinten, B.J. Otten, A.R. Hermus, F.C. Sweep, and C.A. Hulsbergen-van de Kaa Testicular adrenal rest tumors in patients with congenital adrenal hyperplasia can cause severe testicular damage Fertil Steril 89 3 2008 597 601 (Pubitemid 351335029)
35. H.L. Claahsen-van der Grinten, A.R. Hermus, and B.J. Otten Testicular adrenal rest tumours in congenital adrenal hyperplasia Int J Pediatr Endocrinol 2009, vol. 2009, Article ID 624823, 8 pages
36. P.E. Clayton, W.L. Miller, S.E. Oberfield, M.E. Ritzen, W.G. Sippell, and P.W. Speiser Consensus statement on 21-hydroxylase deficiency from the European Society for Paediatric Endocrinology and the Lawson Wilkins Pediatric Endocrine Society Horm Res 58 2002 188 195
37. A. Dauber, H.A. Feldman, and J.A. Majzoub Nocturnal dexamethasone versus hydrocortisone for the treatment of children with congenital adrenal hyperplasia Int J Pediatr Endocrinol 2010 vol. 2010, Article ID 347636, 8 pages
38. M. David, and M.G. Forest Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency J Pediatr 105 5 1984 799 803 (Pubitemid 15206715)
39. K.S. De Silva, S. Kanumakala, J.J. Brown, C.L. Jones, and G.L. Warne 24-hour ambulatory blood pressure profile in patients with congenital adrenal hyperplasia-a preliminary report J Pediatr Endocrinol Metab 17 2004 1089 1095 (Pubitemid 39173390)
40. T. Deak, K.T. Nguyen, A.L. Ehrlich, L.R. Watkins, R.L. Spencer, and S.F. Maier The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress Endocrinology 140 1 1999 79 86 (Pubitemid 29011144)
41. M. Debono, J.N. Price, and R.J. Ross Novel strategies for hydrocortisone replacement Best Pract Res Clin Endocrinol Metab 23 2 2009 221 232
42. H. Derendorf, H. Moellman, J. Barth, C. Moellmann, S. Tunn, and M. Kroeg Pharmacokinetics and oral bioavailability of hydrocortisone J Clin Pharmacol 31 1991 473 476
43. H.G. Dörr Growth in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Horm Res 68 Suppl 5 2007 93 99
44. Dunkel, L. (2006) Use of aromatase inhibitors to increase final height. Mol Cell Endocrinol. 25; 254-255:207-16.
45. E.A. Eugster Aromatase inhibitors in precocious puberty: rationale and experience to date Treat Endocrinol 3 3 2004 141 151 (Pubitemid 38724500)
46. E.A. Eugster, L.A. Dimeglio, J.C. Wright, G.R. Freidenberg, R. Seshadri, and O.H. Pescovitz Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency: a meta-analysis J Pediatr 138 1 2001 26 32 (Pubitemid 32097137)
47. M.M. Fernández-Balsells, K. Muthusamy, G. Smushkin, J.F. Lampropulos, M.B. Elamin, and N.O. Abu Elnour Prenatal dexamethasone use for the prevention of virilization in pregnancies at risk for classical congenital adrenal hyperplasia due to 21hydroxylase (CYP21A2) deficiency: a systematic review and meta-analyses Clin Endocrinol (Oxf) 73 2010 436 444
48. G.P. Finkielstain, W. Chen, S.P. Mehta, F.K. Fujimura, R.M. Hanna, and C. Van Ryzin Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 96 2011 E 161-172
49. J.S. Fuqua, D. Rotenstein, and P.A. Lee Duration of suppression of adrenal steroids after glucocorticoid administration Int J Pediatr Endocrinol 2010 vol. 2010, Article ID 712549, 8 pages
50. A. German, S. Suraiva, Y. Tenenbaum-Rakover, I. Koren, G. Pillar, and Z. Hochberg Control of childhood congenital adrenal hyperplasia and sleep activity and quality with morning or evening glucocorticoide therapy J Clin Endocrinol Metab 93 12 2008 4707
51. G.A. Gmyrek, M.I. New, R.E. Sosa, and D.P. Poppas Bilateral laparoscopic adrenalectomy as a treatment for classic congenital adrenal hyperplasia attributable to 21-hydroxylase deficiency Pediatrics 109 2 2002 E28
52. H. Gotoh, M. Kusakabe, T. Shiroishi, and K. Moriwaki Survival of steroid 21-hydroxylase-deficient mice without endogenous corticosteroids after neonatal treatment and genetic rescue by transgenesis as a model system for treatment of congenital adrenal hyperplasia in humans Endocrinology 135 4 1994 1470 1476
53. M. Gröschl, M. Rauh, and H.G. Dörr Circadian rhythm of salivary cortisol, 17alpha-hydroxyprogesterone, and progesterone in healthy children Clin Chem 49 10 2003 1688 1691
54. K. Hagenfeldt, P.O. Janson, G. Holmdahl, H. Falhammar, H. Filipsson, and L. Frisén Fertility and pregnancy outcome in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Hum Reprod 23 7 2008 1607 1613 (Pubitemid 351809706)
55. S. Hahner, and B. Allolio Therapeutic managemant of adrenal insufficiency Best Pract Res Clin Endocrinol Metab 23 2009 167 179
56. G. Hargitai, J. Solyom, T. Battelino, Z. Pribillincová, R. Hauspie, and J. Kovács Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Result of a multicenter study Horm Res 55 4 2001 161 171 (Pubitemid 34701718)
57. V.J. Heazelwood, J.P. Galligan, G.R. Cannell, F. Bochner, and R.H. Mortimer Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability Br J Clin Pharmacol 17 1984 55 59 (Pubitemid 14054611)
58. M. Hero, O.A. Jänne, K. Näntö-Salonen, L. Dunkel, and T. Raivio Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment J Clin Endocrinol Metab 90 9 2005 5141 5145
59. P.C. Hindmarsh Management of the child with congenital adrenal hyperplasia Best Pract Res Clin Endocrinol Metab 23 2009 193 208
60. W. Hoepffner, A. Herrmann, H. Willgerodt, and E. Keller Blood pressure in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Pediatr Endocrinol Metab 19 2006 705 711
61. I. Hughes Congenital adrenal hyperplasia: phenotype and genotype J Pediatr Endocrinol Metab 15 Suppl 5 2002 1329 1340 (Pubitemid 36024204)
62. J.R. Kerringan, J.D. Veldhuis, S.A. Leyo, H.A. Iranmanes, and A.D. Rogol Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolutkon analysis J Clin Endocrinol Metab 76 1993 1505 1510 (Pubitemid 23164369)
63. N. Krone, A. Braun, A.A. Roscher, D. Knorr, and H.P. Schwarz Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany J Clin Endocrinol Metab 85 2000 1059 1065 (Pubitemid 32269350)
64. N. Krone, B.A. Hughes, G.G. Lavery, P.M. Stewart, W. Arlt, and C.H. Shackleton Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS) J Steroid Biochem Mol Biol 121 3-5 2010 496 504
65. L. Laue, D.P. Merke, J.V. Jones, K.M. Barnes, S. Hill, and G.B. Cutler Jr. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia J Clin Endocrinol Metab 81 10 1996 3535 3539 (Pubitemid 26339911)
66. B.L. Linder, N.V. Esteban, A.L. Yergey, J.C. Winterer, D.L. Loriaux, and F. Cassorla Cortisol production rate in childhood and adolescence J Pediatr 117 1990 892 896
67. K. Lin-Su, M.G. Vogiatzi, I. Marshall, M.D. Harbison, M.C. Macapagal, and B. Betensky Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia J Clin Endocrinol Metab 90 6 2005 3318 3325 (Pubitemid 41014292)
68. K.J. Loechner, J.T. McLaughlin, and A.S. Calikoglu Alternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promises Int J Pediatr Endocrinol 2010 vol. 2010, Article ID 670960, 2010
69. K. Løvås, and E.S. Husebye Continuous subcutaneous hydrocortisone infusion in Addison's disease Eur J Endocrinol 157 1 2007 109 112 (Pubitemid 47162573)
70. P.M. Mah, R.C. Jenkins, A. Rostami-Hodjegan, J. Newell-Price, A. Doane, and V. Ibbotson Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency Clin Endocrinol (Oxf) 61 3 2004 367 375 (Pubitemid 39287067)
71. L. Martinerie, E. Pussard, L. Foix-L'Hélias, F. Petit, C. Cosson, and P. Boileau Physiological partial aldosterone resistance in human newborns Pediatr Res 66 3 2009 323 328
72. D.P. Merke Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 93 3 2008 653 660 (Pubitemid 351398534)
73. D.P. Merke, and S.R. Bornstein Congenital adrenal hyperplasia Lancet 365 9477 2005 2125 2136 (Pubitemid 40826971)
74. D.P. Merke, and G.B. Cutler Jr. New approaches to the treatment of congenital adrenal hyperplasia JAMA 277 13 1997 1073 1076 (Pubitemid 27147547)
75. D.P. Merke, M.F. Keil, J.V. Jones, J. Fields, S. Hill, and G.B. Cutler Jr. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia J Clin Endocrinol Metab 85 3 2000 1114 1120 (Pubitemid 32269358)
76. D.P. Merke, G.P. Chrousos, G. Eisenhofer, M. Weise, M.F. Keil, and A.D. Rogol Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency N Engl J Med 343 19 2000 1362 1368
77. D.P. Merke, D. Cho, K.A. Calis, M.F. Keil, and G.P. Chrousos Hydrocortisone suspension and hydrocortisone tablets are not bioequivalent in the treatment of children with congenital adrenal hyperplasia J Clin Endocrinol Metab 86 1 2001 441 445 (Pubitemid 32109832)
78. D.P. Merke, S.R. Bornstein, N.A. Avila, and G.P. Chrousos NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency Ann Intern Med 136 4 2002 320 334 (Pubitemid 34150761)
79. Z. Merza, A. Rostami-Hodjegan, A. Memmott, A. Doane, V. Ibbotson, and J. Newell-Price Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia Clin Endocrinol (Oxf) 65 1 2006 45 50
80. W.L. Miller The adrenal cortex and its disorders C.G.D. Brook, P. Clayton, R. Brown, Clinical paediatric endocrinology 5th edn. 2001 Blackwell Science Oxford
81. C.F. Mooij, J.M. Kroese, H.L. Claahsen-van der Grinten, C.J. Tack, and A.R. Hermus Unfavourable trends in cardiovascular and metabolic risk in paediatric and adult patients with congenital adrenal hyperplasia Clin Endocrinol (Oxf) 73 2010 137 146
82. J.S. Moore, J.P. Monson, G. Kaltsas, P. Putignano, P.J. Wood, and M.C. Sheppard Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies J Clin Endocrinol Metab 84 1999 4172 4177 (Pubitemid 30644213)
83. C. Moran, R. Azziz, N. Weintrob, S.F. Witchel, V. Rohmer, and D. Dewailly Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia J Clin Endocrinol Metab 91 9 2006 3451 3456 (Pubitemid 44402118)
84. A. Mouritsen, A. Juul, and N. Jørgensen Improvement of semen quality in an infertile man with 21-hydroxylase deficiency, suppressed serum gonadotropins and testicular adrenal rest tumours Int J Androl 33 3 2010 518 520
85. S. Muirhead, E.A. Sellers, H. Guyda Canadian Pediatric Endocrine Group Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia J Pediatr 141 2002 247 252
86. K. Muthusamy, M.B. Elamin, G. Smushkin, M.H. Murad, J.F. Lampropulos, and K.B. Elamin Clinical review: adult height in patients with congenital adrenal hyperplasia: a systematic review and metaanalysis J Clin Endocrinol Metab 95 9 2010 4161 4172
87. T.D. Nebesio, and E.A. Eugster Observation of hypertension in children with 21-hydroxylase deficiency. A preliminary report Endocrine 30 2006 279 282 (Pubitemid 47010963)
88. M.I. New Nonclassical 21-hydroxylase deficiency J Clin Endocrinol Metab 91 11 2006 4205 4214
89. M.I. New, J.M. Gertner, P.W. Speiser, and P. Del Balzo Growth and final height in classical and nonclassical 21-hydroxylase deficiency J Endocrinol Invest 12 1989 91 95 (Pubitemid 19258815)
90. J. Newell-Price, M. Whiteman, A. Rostami-Hodjegan, K. Darzy, S. Shalet, and G.T. Tucker Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers Clin Endocrinol (Oxf) 68 1 2008 130 135 (Pubitemid 350243492)
91. P.G. Newrick, G. Braatvedt, J. Hancock, and R.J. Corrall Self-management of adrenal insufficiency by rectal hydrocortisone Lancet 335 1990 212 213 (Pubitemid 20054589)
92. M.I. Ni Chroinin, M. Fallon, D. Kenny, S. Moriarty, H. Hoey, and C. Costigan Rectal hydrocortisone during vomiting in children with adrenal insufficiency J Pediatr Endocrinol Metab 16 2003 1101 1104 (Pubitemid 37336855)
93. D.A. Nickels, and D.C. Moore Serum cortisol responses in febrile children Pediatr Infect Dis J 8 1989 16 20
94. S. Nimkarn, K. Lin-Su, N. Berglind, R.C. Wilson, and M.I. New Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia J Clin Endocrinol Metab 92 1 2007 137 142 (Pubitemid 46067521)
95. E. Nucera, C. Lombardo, A. Aruanno, A. Colagiovanni, A. Buonomo, and T. De Pasquale "Empty sella syndrome": a case of a patient with sodium-succinate hydrocortisone allergy Eur J Endocrinol 164 2011 139 140
96. W.K. Oelkers Effects of estrogens and progesterons on the renin-aldosterone system and blood pressure Steroids 61 1996 166 171 (Pubitemid 26146736)
97. C.M. Ogilvie, G. Rumsby, T. Kurzawinski, and G.S. Conway Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit's experience Eur J Endocrinol 154 3 2006 405 408
98. B.J. Otten, N.M.M.L. Stikkelbroeck, and A.R.M.M. Hermus Hypogonadism in males with congenital adrenal hyperplasia S.J. Winters, Male hypogonadism: basic, clinical and therapeutic principles 2004 Humana Press Totowa, New Jersey
99. R. Padidela, and P.C. Hindmarsh Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia Int J Pediatr Endocrinol 2010 vol. 2010, Article ID 656925, 4 pages
100. Z. Punthakee, L. Legault, and C. Polychronakos Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency J Pediatr 143 3 2003 402 405 (Pubitemid 37188329)
101. J.B. Quintos, M.G. Vogiatzi, M.D. Harbison, and M.I. New Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia J Clin Endocrinol Metab 86 4 2001 1511 1517 (Pubitemid 32374896)
102. M. Rauh, M. Gröschl, W. Rascher, and H.G. Dörr Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction Steroids 71 6 2006 450 458 (Pubitemid 44294349)
103. N. Reisch, L. Flade, M. Scherr, M. Rottenkolber, F. Pedrosa Gil, and M. Bidlingmaier High prevalence of reduced fecundity in males with congenital adrenal hyperplasia J Clin Endocrinol Metab 94 5 2009 1665 1670
104. F.G. Riepe, N. Krone, M. Viemann, C.J. Partsch, and W.G. Sippell Management of congenital adrenal hyperplasia: results of the ESPE questionnaire Horm Res 58 2002 196 205
105. S. Rivkees Dexamethasone therapy of congenital adrenal hyperplasia and the myth of the "growth toxic" glucocorticoid Int J Pediatr Endocrinol 2010 2010, Article ID 569680, 7 pages
106. S.A. Rivkees, and J.D. Crawford Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth Pediatrics 106 4 2000 767 773
107. S.A. Rivkees, and K. Stephenson Low-dose dexamethasone therapy from infancy of virilizing congenital adrenal hyperplasia Int J Pediatr Endocrinol 2009 2009, Article ID 274682, 4 pages
108. E.F. Roche, E. Charmandari, M.T. Dattani, and P.C. Hindmarsh Blood pressure in children and adolescents with congenital adrenal hyperplasia (21-hydroxylase deficiency): a preliminary report Clin Endocrinol 58 2003 589 596 (Pubitemid 36566800)
109. R.L. Rosenfield Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia J Clin Endocrinol Metab 87 2002 2993 (Pubitemid 34655377)
110. A. Rösler, L.S. Levine, B. Schneider, M. Novogroder, and M.I. New The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia J Clin Endocrinol Metab 45 1977 500 512 (Pubitemid 8194487)
111. P. Sartorato, E. Zulian, S. Benedini, B. Mariniello, F. Schiavi, and F. Bilora Cardiovascular risk factors and ultrasound evaluation of intima-media thickness at common carotids, carotid bulbs, and femoral and abdominal aorta arteries in patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 92 3 2007 1015 1018 (Pubitemid 46465677)
112. I. Shimon, I. Kaiserman, and J. Sack Home monitoring of 17 alpha-hydroxyprogesterone levels by filter paper blood spots in patients with 21-hydroxylase deficiency Horm Res 44 6 1995 247 252 (Pubitemid 26026491)
113. D.I. Shulman, M.R. Palmert, S.F. Kemp Lawson Wilkins Drug and Therapeutics Committee Adrenal insufficiency: still a cause of morbidity and death in childhood Pediatrics 199 2 2007 e484 e494 (Pubitemid 46397798)
114. A.T. Soliman, M. AlLamki, I. AlSalmi, and M. Asfour Congenital adrenal hyperplasia complicated by central precocious puberty: linear growth during infancy and treatment with gonadotropin-releasing hormone analog Metabolism 46 5 1997 513 517 (Pubitemid 27214873)
115. P.W. Speiser Nonclassic adrenal hyperplasia Rev Endocr Metab Disord 10 2009 77 82
116. P.W. Speiser, and P.F. White Congenital adrenal hyperplasia N Engl J Med 349 2003 776 788 (Pubitemid 37010783)
117. P.W. Speiser, J. Dupont, D. Zhu, J. Serrat, M. Buegeleisen, and M.T. Tusie-Luna Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Invest 90 2 1992 584 595
118. P.W. Speiser, R. Azziz, L.S. Baskin, L. Ghizzoni, T.W. Hensle, and D.P. Merke Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline J Clin Endocrinol Metab 95 2010 4133 4160
119. P.D. Stenson The Human Gene Mutation Database (HGMD®): Update 2008 Accessible via http://www.hgmd.cf.ac.uk/ac/gene.php?gene=CYP21A2
120. N.M. Stikkelbroeck, C.G. Sweep, D.D. Braat, A.R. Hermus, and B.J. Otten Monitoring of menstrual cycles, ovulation, and adrenal suppression by saliva sampling in female patients with 21-hydroxylase deficiency Fertil Steril 80 4 2003 1030 1036 (Pubitemid 37230044)
121. N.M. Stikkelbroeck, A.R. Hermus, D.D. Braat, and B.J. Otten Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency Obstet Gynecol Surv 58 4 2003 275 284 (Pubitemid 36407196)
122. N.M. Stikkelbroeck, B.A. Van'tHof-Grootenboer, A.R. Hermus, B.J. Otten, and M.A. Van't Hof Growth inhibition by glucocorticoid treatment in salt wasting 21-hydroxylase deficiency: in early infancy and (pre) puberty J Clin Endocrinol Metab 88 8 2003 3525 3530 (Pubitemid 37034490)
123. N.M. Stikkelbroeck, L.H. Hoefsloot, I.J. De Wijs, B.J. Otten, A.R. Hermus, and E.A. Sistermans CYP21 gene mutation analysis in 198 patients with 21-hydroxylase deficiency in The Netherlands: six novel mutations and a specific cluster of four mutations J Clin Endocrinol Metab 88 8 2003 3852 3859 (Pubitemid 37034538)
124. N.M. Stikkelbroeck, A.R. Hermus, H.M. Suliman, G.J. Jager, and B.J. Otten Asymptomatic testicular adrenal rest tumors in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years J Pediatr Endocrinol Metab 17 4 2004 645 653 (Pubitemid 38931061)
125. T. Tajima, T. Okada, X.M. Ma, W. Ramsey, S. Bornstein, and G. Aguilera Restoration of adrenal steroidogenesis by adenovirus-mediated transfer of human cytochrome P450 21-hydroxylase into the adrenal gland of 21-hydroxylase- deficient mice Gene Ther 6 1999 1898 1903 (Pubitemid 29531286)
126. D. Tiosano, E. Vlodavsky, S. Filmar, Z. Weiner, D. Goldsher, and R. Bar-Shalom Ovarian adrenal rest tumor in a congenital adrenal hyperplasia patient with adrenocorticotropin hypersecretion following adrenalectomy Horm Res Paediatr 74 3 2010 223 228
127. H.J. Van der Kamp, B.J. Otten, N. Buitenweg, S.M. De Muinck Keizer-Schrama, W. Oostdijk, and M. Jansen Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients Arch Dis Child 87 2002 139 144 (Pubitemid 34828021)
128. J.J. Van Wyk, and E.M. Ritzen The role of bilateral adrenalectomy in the treatment of congenital adrenal hyperplasia J Clin Endocrinol Metab 88 7 2003 2993 2998 (Pubitemid 36877460)
129. S. Verma, C. Vanryzin, N. Sinaii, M.S. Kim, L.K. Nieman, and Ravindran A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia Clin Endocrinol (Oxf) 72 4 2010 441 447
130. J. Voisey, L. Carroll, and A. Van Daal Melanocortins and their receptors and antagonists Curr Drug Targets 4 7 2003 586 597 (Pubitemid 37139051)
131. T.M.K. Völkl, D. Simm, J. Dötsch, W. Rascher, and H.G. Dörr Altered 24-hour blood pressure profiles in children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency J Clin Endocrinol Metab 91 2006 4888 4895 (Pubitemid 44917323)
132. T.M. Völkl, D. Simm, A. Körner, W. Rascher, W. Kiess, and J. Kratzsch Does an altered leptin axis play a role in obesity among children and adolescents with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency? Eur J Endocrinol 160 2 2009 239 247
133. M. Vroede, R. Beukering, M. Spit, and M. Jansen Rectal hydrocortisone during stress in patients with adrenal insufficiency Arch Dis Child 78 1998 544 547 (Pubitemid 28274697)
134. B.L. Wajchenberg Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome Endocr Rev 21 6 2000 697 738 (Pubitemid 32113289)
135. M. Weise, B. Drinkard, S.L. Mehlinger, S.M. Holzer, G. Eisenhofer, and E. Charmandari Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise J Clin Endocrinol Metab 89 2004 3679 3684 (Pubitemid 39071454)
136. M. Weise, S.L. Mehlinger, B. Drinkard, E. Rawson, E. Charmandari, and M. Hiroi Patients with classic congenital adrenal hyperplasia have decreased epinephrine reserve and defective glucose elevation in response to high-intensity exercise J Clin Endocrinol Metab 89 2 2004 591 597 (Pubitemid 38269863)
137. P.C. White, and P.W. Speiser Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Endocr Rev 21 2000 245 291 (Pubitemid 32275589)
138. S. Wickman, I. Sipilä, C. Ankarberg-Lindgren, E. Norjavaara, and L.A. Dunkel Specific aromatase inhibitor and potential increase in adult height in boys with delayed puberty: a randomised controlled trial Lancet 357 9270 2001 1743 1748 (Pubitemid 32524203)
139. J. Wischusen, H.W. Baker, and B. Hudson Reversible male infertility due to congenital adrenal hyperplasia Clin Endocrinol (Oxf) 14 1981 571 577 (Pubitemid 11059673)
140. T. Yazawa, T. Mizutani, K. Yamada, H. Kawata, T. Sekiguchi, and M. Yoshino Differentiation of adult stem cells derived from bone marrow stroma into Leydig or adrenocortical cells Endocrinology 147 9 2006 4104 4111 (Pubitemid 44268363)
141. M.C. Young, J.A. Robinson, G.F. Read, D. Riad-Fahmy, and I.A. Hughes 17OH-progesterone rhythms in congenital adrenal hyperplasia Arch Dis Child 63 1988 617 623
142. M.C. Young, R.F. Walker, D. Riad-Fahmy, and I.A. Hughes Androstenedione rhythms in congenital adrenal hyperplasia Arch Dis Child 63 1988 624 628
143. E. Zoumakis, and G.P. Chrousos Corticotropin-releasing hormone receptor antagonists: an update Endocr Dev 17 2010 36 43